Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
@article{Lavanchy2004HepatitisBV, title={Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures}, author={Daniel Lavanchy}, journal={Journal of Viral Hepatitis}, year={2004}, volume={11} }
Summary. Hepatitis B virus (HBV) infection is a serious global health problem, with 2 billion people infected worldwide, and 350 million suffering from chronic HBV infection. The 10th leading cause of death worldwide, HBV infections result in 500 000 to 1.2 million deaths per year caused by chronic hepatitis, cirrhosis, and hepatocellular carcinoma; the last accounts for 320 000 deaths per year [ 1, 2 ]. In Western countries, the disease is relatively rare and acquired primarily in adulthood… CONTINUE READING
Topics from this paper
Paper Mentions
Interventional Clinical Trial
TAF is a new prodrug of tenofovir, specifically designed to achieve higher intracellular
active drug concentration allowing for dosing of only 25 mg once daily and thus can… Expand
Conditions | HBV |
---|---|
Intervention | Drug |
Interventional Clinical Trial
Currently, five nucleos(t)ide analogs are approved for the treatment of chronic hepatitis B,
namely lamivudine, adefovir dipivoxil, telbivudine, entecavir (ETV) and tenofovir disoproxil… Expand
Conditions | Chronic Heptitis B |
---|---|
Intervention | Drug |
Interventional Clinical Trial
Randomized open-label substudy of daily Myrcludex B (MXB) plus pegylated interferon-alpha-2a
(PEG-INF-a) in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B virus… Expand
Conditions | Chronic Hepatitis D Infection |
---|---|
Intervention | Drug |
Interventional Clinical Trial
A randomized, open-label multicentre clinical trial of daily Myrcludex B versus entecavir in
patients with HBeAg negative chronic hepatitis B.
Conditions | Chronic Hepatitis B |
---|---|
Intervention | Drug |
2,425 Citations
Toward elimination and eradication of hepatitis B
- Medicine
- Journal of gastroenterology and hepatology
- 2010
- 76
Prevention of hepatitis B virus infection by vaccination: Progress and problems
- Medicine
- Hepatology research : the official journal of the Japan Society of Hepatology
- 2007
- 3
References
SHOWING 1-10 OF 106 REFERENCES
Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection
- Medicine
- Clinical Microbiology Reviews
- 1999
- 447
- PDF
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
- Medicine
- Annals of Internal Medicine
- 2000
- 162
Development of recommendations for control of hepatitis B virus infections: the role of cost analysis.
- Medicine
- Vaccine
- 1990
- 25
Cost-effectiveness of Interferon-2b Treatment for Hepatitis B e Antigen-Positive Chronic Hepatitis B
- Medicine
- Annals of Internal Medicine
- 1995
- 216
Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness.
- Medicine
- Vaccine
- 1999
- 36
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
- Medicine
- Annals of Internal Medicine
- 2001
- 398
Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination
- Medicine
- Annals of Internal Medicine
- 2001
- 344
- PDF
Epidemiology of hepatitis B virus infection in the Asia–Pacific region
- Medicine
- Journal of gastroenterology and hepatology
- 2000
- 238